Clinical Trial

Clozapine in Treatment Resistant Schizophrenia

Study Description

Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study

The purpose of this study is to investigate the relationship between glutamate and related brain chemicals and treatment response to clozapine in patients with treatment-resistant schizophrenia.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Clozapine

Patient participants will be starting clozapine as part of their clinical care.

Additional Information

Official Study Title

Glutamatergic System and Response to Clozapine in Patients With Treatment-Resistant Schizophrenia: a Prospective Proton Magnetic Resonance Spectroscopy Study

Clinical Trial ID

NCT02714894

ParticipAid ID

PdRBwd